The infant microbiome and its impact on development of food allergy KN Jungles, KM Jungles, L Greenfield, M Mahdavinia Immunology and Allergy Clinics 41 (2), 285-299, 2021 | 16 | 2021 |
RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes AM Pesch, NH Hirsh, AR Michmerhuizen, KM Jungles, K Wilder-Romans, ... JCI insight 7 (3), 2022 | 11 | 2022 |
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models AR Michmerhuizen, LM Lerner, AM Pesch, C Ward, R Schwartz, ... NPJ Breast Cancer 8 (1), 31, 2022 | 7 | 2022 |
High-content CRISPR screening in tumor immunology EA Holcomb, AN Pearson, KM Jungles, A Tate, J James, L Jiang, ... Frontiers in Immunology 13, 1041451, 2022 | 6 | 2022 |
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer KM Jungles, EA Holcomb, AN Pearson, KR Jungles, CR Bishop, ... Frontiers in Oncology 12, 1022542, 2022 | 6 | 2022 |
Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression AM Pesch, BC Chandler, AR Michmerhuizen, HM Carter, NH Hirsh, ... Cancer research communications 2 (7), 679-693, 2022 | 4 | 2022 |
Catalase deficiency compromises survival in extracellular matrix-detached SKOV3 ovarian cancer cells CL Libbing, KM Jungles, E Rabaut, CA Davison-Versagli React Oxyg Species (Apex) 7 (20), 121-8, 2019 | 3 | 2019 |
Fat fuels the fire in cervical cancer KM Jungles, MD Green Cancer Research 82 (24), 4513-4514, 2022 | 2 | 2022 |
Transcriptomic Analysis to Uncover the Mechanism of Radiosensitization of AR-Positive Triple Negative Breast Cancers with AR Inhibition CE Pisano, B McBean, AR Michmerhuizen, B Chandler, A Pesch, C Ward, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e255, 2023 | 1 | 2023 |
Peroxiredoxin 2 controls proliferation in extracellular matrix-detached SKOV3 ovarian cancer cells KM Jungles, D Bondarenko, M Sanchez, KA Schramm, ... Reactive Oxygen Species 9 (27), 109–117-109–117, 2020 | 1 | 2020 |
Targeting aurora kinase B (AURKB) as a radiosensitizing strategy in syngeneic models of triple negative breast cancer (TNBC) KM Jungles, Z Wang, C Bishop, C Wilson, M Liu, J James, M Green, ... Cancer Research 84 (6_Supplement), 708-708, 2024 | | 2024 |
Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer Q Zhang, L Jiang, W Wang, AK Huber, VM Valvo, KM Jungles, ... JCI insight, 2024 | | 2024 |
Liver Metastases Potentiate Cancer Progression AN Pearson, E Holcomb, J James, KM Jungles, N Nedzesky, G Schaefer, ... The Journal of Immunology 210 (1_Supplement), 88.09-88.09, 2023 | | 2023 |
The radiosensitizing effects of monopolar spindle kinase I in syngeneic models of triple negative breast cancer and its implications on the tumor immune microenvironment KM Jungles, Z Wang, C Bishop, KR Jungles, C Wilson, M Liu, AN Pearson, ... The Journal of Immunology 210 (1_Supplement), 245.06-245.06, 2023 | | 2023 |
CRISPR-Cas9 screen identifies potential novel regulators of CD8+ T cell dysfunction EA Holcomb, L Jiang, A Tate, AN Pearson, Z Wang, KM Jungles, J James, ... The Journal of Immunology 210 (1_Supplement), 86.13-86.13, 2023 | | 2023 |
Targeting monopolar spindle kinase I (TTK) as a radiosensitizing strategy in syngeneic murine models of triple negative breast cancer (TNBC) and its implications on the tumor … KM Jungles, Z Wang, CR Bishop, KR Jungles, C Wilson, M Liu, ... Cancer Research 83 (7_Supplement), 2823-2823, 2023 | | 2023 |
Conoidin A Abrogates Growth of Anchorage-Dependent and Anchorage-Independent SKOV3 Ovarian Cancer Cells KM Borger, KM Jungles, M Powell, M Sanchez, CA Davison-Versagli Reactive Oxygen Species 12, r9–r17-r9–r17, 2022 | | 2022 |
Inhibition of estrogen receptor signaling as a strategy for radiosensitization of ER+ breast cancers AR Michmerhuizen, LM Lerner, AM Pesch, C Ward, R Schwartz, ... Cancer Research 82 (12_Supplement), 2697-2697, 2022 | | 2022 |
Expression of DNA damage response proteins modifies the efficacy of CDK4/6 inhibitor-mediated radiosensitization in breast cancer models KM Jungles, AM Pesch, N Hirsh, AR Michmerhuizen, K Wilder-Romans, ... Cancer Research 82 (12_Supplement), 216-216, 2022 | | 2022 |